02.06.2014
- German drugmaker Boehringer Ingelheim has said it will pay about $650 million to settle US lawsuits that claimed the company's blockbuster blood thinner, Pradaxa (dabigatran)...
20.02.2014
- German pharmaceutical producer Boehringer Ingelheim is being confronted in the U.S. with more than 2,000 lawsuits related to its blood thinner Pradaxa (dabigatran). The plaintiffs...
20.12.2013
- The Supervisory Board of Bayer AG appointed Kemal Malik (51) to the Board of Management of Bayer AG effective February 1, 2014. Malik has been a member of the Bayer HealthCare...
05.11.2013
- With three quarters of 2013 behind it, Germany's Bayer group sees itself as still on track to fulfil the "ambitious forecast" for 2013 voiced by CEO Marijn Dekkers earlier this...
30.07.2013
- Expectations that Bayer will embrace a trend in the pharma sector to split off non-core units may be too far ahead of the curve. The diversified German healthcare group has an...
03.12.2012
- Success Factors - With numerous new products, the Bayer Group aims to help improve people's lives while exploiting billions in potential sales. "Innovation is the only way to...
